Your session is about to expire
← Back to Search
Unipolar Polarity Switch for Atrial Fibrillation
Study Summary
This trial showed that a new technique for measuring lesion effectiveness during ablation procedures led to shorter procedures, less radiation exposure, and better outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent by myself.I do not have newly diagnosed atrial fibrillation.I am 18 years old or older.I am scheduled for a procedure to treat new onset atrial fibrillation.
- Group 1: Unipolar Polarity Switch Left and CAI-OPR-LAAP Right
- Group 2: CAI-OPR-LAAP Left and Unipolar Polarity Switch Right
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any patients who have yet to be enrolled in this clinical trial?
"This specific trial, as detailed on clinicaltrials.gov, is not looking for new patients at this time. Although the last update was on July 14th, 2022, this could change in the future. There are 500 other trials, however, that are actively recruiting patients."
What goals does this medical study hope to reach?
"The primary goal of this one-year study is to compare the number of patients who need open heart surgery. Additionally, the six-month freedom from atrial fibrillation (AF), compare 1st pass isolation in the Unipolar polarity switch group to Carto's Ablation Index per Overland Park Regional's Left Atrial Ablation Protocol (CAI-OPR-LAAP), and validate Near Field and Far Field Discrimination with High Frequency Algorithm as a confirmation tool will be assessed as secondary outcomes."
Share this study with friends
Copy Link
Messenger